Trial Profile
Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DB-020 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2020
Price :
$35
*
At a glance
- Drugs Sodium thiosulfate (Primary) ; Hyaluronic acid
- Indications Sensorineural hearing loss
- Focus Adverse reactions
- Sponsors Decibel Therapeutics
- 26 Mar 2020 Results presented in a Decibel Therapeutics Media Release.
- 10 Mar 2020 Results published in the Investigational New Drugs
- 17 May 2019 Status changed from not yet recruiting to completed.